Stoke Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
All right. Good afternoon, everyone. Welcome back to the next session of the SVB Securities Global Biopharma Conference. My name is Rudy Li. I'm from SVB Securities equity research team. So it's my pleasure today to host a fireside chat with Stoke Therapeutics. Joining us today is Barry Ticho, Chief Medical Officer of the company. So for investors who join us today, feel free to send me questions on webcast or you can email me at [email protected]. And with that, let's get it started. So thanks for joining us, Barry.
Questions & Answers
So for those who are not familiar with your story, maybe we spend a couple of minutes. Give us a brief introduction of the company, the background, the history, and how do we get there?
Certainly, thank you, Rudy. Thanks for the invitation. It's a pleasure being able to speak to you and to your guests. Just as a quick background, my name
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |